Peregrine Pharma New
(PPHM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPHM | SABS | HUMA | ||
| Company | Peregrine Pharma New | Sab Biotherapeutics Inc | Humacyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.24 | 4.17 | 1.0150 | ||
| High | 4.25 | 4.26 | 1.0400 | ||
| Low | 4.18 | 4.06 | 0.9808 | ||
| Latest | 4.22 | 4.12 | 1.0100 | ||
| Change | +0.03 | -0.06 | unch | ||
| % Change | +0.72% | -1.44% | unch | ||
| Volume | 93,000 | 307,300 | 6,879,800 | ||
| 20-Day Average Volume | 254,905 | 411,710 | 6,207,935 | ||
| Previous Close | 4.19 | 4.18 | 1.0100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.24 | 4.18 | 1.0275 | ||
| 20-Day Raw Stochastic | 27.59% | 39.78% | 31.71% | ||
| 20-Day Relative Strength | 48.73 | 53.06 | 46.60 | ||
| Weighted Alpha | +32.90 | +90.50 | -70.98 | ||
| Today's Opinion | N/A | 80% Buy | 96% Sell | ||
| Previous Opinion | N/A | 96% Buy | 96% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.76% since 12/29/17 | +3.52% since 02/05/26 | +13.97% since 02/05/26 | ||
| Low | 3.88 on 01/02/18 | 3.75 on 02/06/26 | 0.9020 on 02/06/26 | ||
| High | 4.25 on 01/05/18 | 4.30 on 02/11/26 | 1.2900 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -19.77% since 12/05/17 | +10.16% since 01/12/26 | -10.62% since 01/12/26 | ||
| Low | 3.74 on 12/21/17 | 3.68 on 01/13/26 | 0.8800 on 02/05/26 | ||
| High | 5.48 on 12/11/17 | 4.68 on 02/02/26 | 1.2900 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +23.39% since 10/05/17 | +20.82% since 11/12/25 | -19.20% since 11/12/25 | ||
| Low | 3.28 on 10/09/17 | 3.00 on 11/14/25 | 0.8800 on 02/05/26 | ||
| High | 5.48 on 12/11/17 | 4.68 on 02/02/26 | 1.3800 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | -4.31% since 07/05/17 | +90.74% since 08/12/25 | -43.73% since 08/12/25 | ||
| Low | 2.85 on 09/08/17 | 1.85 on 09/30/25 | 0.8800 on 02/05/26 | ||
| High | 5.78 on 07/14/17 | 4.68 on 02/02/26 | 2.5500 on 10/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 190,786 | 198,997 | 189,144 | ||
| Shares Outstanding, K | 45,210 | 47,607 | 187,271 | ||
| Annual Sales | 57,630,000 | 1,320,000 | 0 | ||
| Annual Net Income | -28,160,000 | -34,110,000 | -148,700,000 | ||
| Last Quarter Sales | 12,780,000 | 0 | 750,000 | ||
| Last Quarter Net Income | -12,620,000 | 45,450,000 | -17,510,000 | ||
| 60-Month Beta | 2.74 | 0.59 | 1.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 09/11/17 | -0.21 on 11/14/25 | -0.14 on 11/12/25 | ||
| Latest Earnings Date | 03/12/18 | 03/27/26 | 03/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||